Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)

Bibliographic Details
Main Authors:	Quartier, P, Allantaz, F, Cimaz, R, Pillet, P, Richer, O, Desjonqueres, M, Duquesne, A, Messiaen, C, Bardin, C, Bossuyit, X, Boutten, A, Bienvenu, J, Menoni, V, Sotou-Bere, S, Neven, B, Mahloui, N, Mogenet, A, Kassai, B, Chaussabel, D, Treluyer, JM, Bresson, JL, Landais, P, Pascual, V
Format:	Online
Language:	English
Published:	BioMed Central 2008
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334078/

id	pubmed-3334078
recordtype	oai_dc
spelling	pubmed-33340782012-04-24 Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS) Quartier, P Allantaz, F Cimaz, R Pillet, P Richer, O Desjonqueres, M Duquesne, A Messiaen, C Bardin, C Bossuyit, X Boutten, A Bienvenu, J Menoni, V Sotou-Bere, S Neven, B Mahloui, N Mogenet, A Kassai, B Chaussabel, D Treluyer, JM Bresson, JL Landais, P Pascual, V Poster Presentation BioMed Central 2008-09-15 /pmc/articles/PMC3334078/ http://dx.doi.org/10.1186/1546-0096-6-S1-P27 Text en Copyright ©2008 Quartier et al; licensee BioMed Central Ltd.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Quartier, P Allantaz, F Cimaz, R Pillet, P Richer, O Desjonqueres, M Duquesne, A Messiaen, C Bardin, C Bossuyit, X Boutten, A Bienvenu, J Menoni, V Sotou-Bere, S Neven, B Mahloui, N Mogenet, A Kassai, B Chaussabel, D Treluyer, JM Bresson, JL Landais, P Pascual, V
spellingShingle	Quartier, P Allantaz, F Cimaz, R Pillet, P Richer, O Desjonqueres, M Duquesne, A Messiaen, C Bardin, C Bossuyit, X Boutten, A Bienvenu, J Menoni, V Sotou-Bere, S Neven, B Mahloui, N Mogenet, A Kassai, B Chaussabel, D Treluyer, JM Bresson, JL Landais, P Pascual, V Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)
author_facet	Quartier, P Allantaz, F Cimaz, R Pillet, P Richer, O Desjonqueres, M Duquesne, A Messiaen, C Bardin, C Bossuyit, X Boutten, A Bienvenu, J Menoni, V Sotou-Bere, S Neven, B Mahloui, N Mogenet, A Kassai, B Chaussabel, D Treluyer, JM Bresson, JL Landais, P Pascual, V
author_sort	Quartier, P
title	Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)
title_short	Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)
title_full	Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)
title_fullStr	Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)
title_full_unstemmed	Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)
title_sort	efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (anajis)
description
publisher	BioMed Central
publishDate	2008
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334078/
_version_	1611523769710411776

Efficacy, safety and effect on gene expression profiling of anakinra in systemic-onset juvenile idiopathic arthritis: final results of a randomised, double-blind, placebo-controlled trial (ANAJIS)

Similar Items